Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 347

UBiqube nets NTT Comware on way to $20m

NTT Comware has agreed to take part in a series B round the corporate-backed orchestration software producer intends to close at $20m.

Apr 10, 2019

InMotion heads to The Out

Jaguar Land Rover's corporate VC unit has diversified from its external investments to launch a car rental service in London called The Out.

Apr 10, 2019

Avectas collects $10m

NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.

Apr 10, 2019

Monzo to put $130m on its books

The deal will double the Orange and Stripe-backed digital bank’s valuation to $2.6bn, making it the second most valuable fintech developer in the UK.

Apr 10, 2019

Fliit fits in series A funding

AP Moller – Maersk took part in an $11.2m round that will accelerate the international expansion of the food logistics marketplace.

Apr 10, 2019

Theya settles into $750,000

NovaUCD-based patient lingerie manufacturer Theya Healthcare has been backed by investors including Enterprise Ireland as it prepares for expansion in the US.

Apr 9, 2019

Reeve takes chair at Albion Capital

Patrick Reeve, managing partner at Albion Capital, which manages UCL Technology Fund, has passed his position onto his deputy to become the firm’s first chairman.

Apr 9, 2019

Liopa gets more than lip service in seed round

Queen’s University Belfast speech recognition technology spinout Liopa is working on a product that analyses lip movements to provide more robust analysis in noisy environments.

Apr 8, 2019

Property Finder locates Zingat for another investment

Property Finder has increased its stake in online property listings platform Zingat from nearly 17% to 37% with an investment of about $12m.

Apr 8, 2019

Boehringer Ingelheim regenerates Agomab

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer that was co-led by V-Bio Ventures and Advent France Biotechnology.

Apr 8, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here